Accelerate your therapeutic pipeline with a fast, GMP‑compliant, cost‑effective synthesis service designed for corporate purchasing managers, technical directors, and operations leaders.
In 2025‑2026, more than 62 % of biotech firms reported delays in peptide‑based drug programs because of unreliable contract manufacturers. Below are the three‑to‑six core frustrations you most likely face:
These challenges translate into 30‑45 % higher overall project cost and jeopardize market entry timelines. What if you could eliminate all five obstacles with a single partner?
Global Technology Co., Ltd leverages a state‑of‑the‑art peptide factory in Zhengzhou, China, integrated with GMP‑certified subcontractors from leading universities. We deliver:
| Parameter | Standard Offering | Custom Option |
|---|---|---|
| Scale | 10 g – 500 g | 1 kg – 10 t |
| Purity (HPLC) | ≥ 95 % | ≥ 99 % (Ultra‑Pure) |
| Delivery Time | 30 days | 15 days (express) |
| Certificate | COA, GMP, ISO 9001 | COA, GMP, FDA‑DMF, CE, RoHS |
| Shipping | Air (DDP) or Sea (FOB) | Cold‑chain air freight, customs‑cleared |
Scenario 1 – Pre‑clinical Incretin Research: A US‑based biotech needed 50 g of a high‑purity GIP glucagon analog for mouse PK studies. We delivered 48 g of 99.2 % purity within 22 days, cutting their projected cost by 28 % and enabling a 3‑month earlier IND filing.
Scenario 2 – GMP‑Batch for Phase I Clinical Trial: A European CRO required 200 g of GMP‑grade analog with full regulatory documentation. Our integrated DMF filing and 30‑day turnaround met EMA expectations, resulting in a 95 % success rate for on‑time trial start.
These examples illustrate how our high‑speed, cost‑transparent, quality‑first approach solves the exact challenges described above.
Standard batches (10 g – 500 g) are delivered within 30 calendar days. Express orders (≤ 200 g) can be completed in 15 days with air‑freight priority.
Yes. Every batch includes a Certificate of Analysis, GMP batch record, and, upon request, a DMF dossier compatible with FDA, EMA, and Health Canada requirements.
Absolutely. Our modular synthesis lines enable seamless scale‑up to 10 tons while maintaining ≤ 0.5 % impurity variation across batches.

We provide an upfront, item‑level freight quote. Both DDP (Delivered Duty Paid) and FOB options are available; DDP typically adds 5‑7 % to the product price but eliminates customs surprises.
Every batch undergoes HPLC purity, LC‑MS molecular weight confirmation, amino‑acid analysis, endotoxin testing (≤ 0.5 EU/mL), residual solvent analysis (GC‑MS), and stability testing at 4 °C, –20 °C, and ambient conditions.
Secure your risk‑free trial now—no upfront payment, no hidden fees. Supplies are limited to the first 20 inquiries each month.
All communications are secured under our privacy policy. Your data will never be shared with third parties.
John M., Procurement Manager, BioGen Labs – “The speed and price transparency were game‑changing. We received a 200 g GMP batch 4 days before the deadline, saving $9,500.”
Linda S., Technical Director, NovaThera – “Their analytical package is exhaustive. The COA matched our internal assay within 0.2 %—a level of consistency we haven’t seen elsewhere.”
Mark T., COO, PharmEdge – “We needed a regulated supply chain for a Phase II trial. Global Technology’s DMF support and DDP shipping removed all regulatory friction.”
Global Technology Co., Ltd – Your trusted partner for Custom GIP glucagon analog synthesis and a full suite of peptide & API solutions.
Address: No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China
Tel: +86 199 4383 0844 | Email: service@huanqiukeji9.com
Visit our Contact Page for a personalized quote.
Trusted by Industry Leaders Worldwide
Our client portfolio spans Fortune‑500 pharma, top‑tier CROs, and fast‑growing biotech startups.
Biotin-Obestatin-human-conjugate-supplier Ammonium-phosphate AB70 CAS-1262780-97-1-Semaglutide
All products are manufactured under ISO 9001, GMP, FDA, CE, RoHS, and VDE standards. Our facilities hold CE, FDA, and ISO certifications, guaranteeing compliance across North America, Europe, and Asia‑Pacific markets.